Clinical outcomes of coronavirus disease 2019 in patients with pre-existing liver diseases: A multicenter study in South Korea

Clinical outcomes of coronavirus disease 2019 in patients with pre-existing liver diseases: A multicenter study in South Korea

Background/Aims Although coronavirus disease 2019 (COVID-19) has spread rapidly worldwide, the implication of pre-existing liver disease on the outcome of COVID-19 remains unresolved. Methods A total of 1,005 patients who were admitted to five tertiary hospitals in South Korea with laboratory-confir...

Full description

Bibliographic Details
Main Authors:	Yu Rim Lee, Min Kyu Kang, Jeong Eun Song, Hyun Jung Kim, Young Oh Kweon, Won Young Tak, Se Young Jang, Jung Gil Park, Changhyeong Lee, Jae Seok Hwang, Byoung Kuk Jang, Jeong Ill Suh, Woo Jin Chung, Byung Seok Kim, Soo Young Park
Format:	Article
Language:	English
Published:	Korean Association for the Study of the Liver 2020-10-01
Series:	Clinical and Molecular Hepatology
Subjects:	liver diseases liver cirrhosis prognosis mortality covid-19
Online Access:	http://e-cmh.org/upload/pdf/cmh-2020-0126.pdf

Similar Items

Effects of Branched-Chain Amino Acid (BCAA) Supplementation on the Progression of Advanced Liver Disease: A Korean Nationwide, Multicenter, Prospective, Observational, Cohort Study
by: Jung Gil Park, et al.
Published: (2020-05-01)

The cut-off value of transient elastography to the value of hepatic venous pressure gradient in alcoholic cirrhosis
by: Se Ri Ryu, et al.
Published: (2021-01-01)

The refit model for end-stage liver disease-Na is not a better predictor of mortality than the refit model for end-stage liver disease in patients with cirrhosis and ascites
by: Jun Jae Kim, et al.
Published: (2014-03-01)

Clinical outcomes of transjugular intrahepatic portosystemic shunt for portal hypertension: Korean multicenter real-practice data
by: Hyung Ki Kim, et al.
Published: (2014-03-01)

Primary hepatic sarcoidosis presenting with cholestatic liver disease and mimicking primary biliary cholangitis: a case report
by: Young Joo Park, et al.
Published: (2022-07-01)

Model for end-stage liver disease-3.0 vs. model for end-stage liver disease-sodium: mortality prediction in Korea
by: Jeong Han Kim, et al.
Published: (2024-03-01)

Liver Stiffness-Based Risk Prediction Model for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease
by: Jae Seung Lee, et al.
Published: (2021-09-01)

Clinical outcomes of balloon-occluded retrograde transvenous obliteration for the treatment of gastric variceal hemorrhage in Korean patients with liver cirrhosis: a retrospective multicenter study
by: Se Young Jang, et al.
Published: (2012-12-01)

Transient elastography with controlled attenuation parameter versus two-dimensional shear wave elastography with attenuation imaging for the evaluation of hepatic steatosis and fibrosis in NAFLD
by: Jung Wook Seo, et al.
Published: (2023-07-01)

Association of Myosteatosis with Nonalcoholic Fatty Liver Disease, Severity, and Liver Fibrosis Using Visual Muscular Quality Map in Computed Tomography
by: Hwi Seung Kim, et al.
Published: (2023-01-01)

Cyanoacrylate injection versus band ligation for bleeding from cardiac varices along the lesser curvature of the stomach
by: Sang Jung Park, et al.
Published: (2016-12-01)

Ultrasonographic morphological diagnosis of chronic liver disease: 2-dimensional shear wave elastography as an add-on test
by: Young Seo Cho, et al.
Published: (2020-07-01)

The Clinical Courses and Prognosis of Cirrhotic Patients after First Acute Decompensation: Prospective Cohort Study
by: Jung Hee Kim, et al.
Published: (2023-12-01)

Clinical Features of Spontaneous Bacterial Peritonitis: A 10-year Experience from a Single Center
by: Ha Young Na, et al.
Published: (2017-02-01)

Diagnostic Efficacy of Serum Asialo α1-Acid Glycoprotein Levels for Advanced Liver Fibrosis and Cirrhosis in Patients with Chronic Hepatitis B Compared to That in Healthy Subjects: A Prospective Study
by: Yoonseok Lee, et al.
Published: (2023-01-01)

Evidence-based hyponatremia management in liver disease
by: Ji Young Ryu, et al.
Published: (2023-10-01)

Serum S100B Levels in Patients with Liver Cirrhosis and Hepatic Encephalopathy
by: Mo-Jong Kim, et al.
Published: (2023-01-01)

Time-dependent reversal of significant intrapulmonary shunt after liver transplantation
by: Xin Jin, et al.
Published: (2019-05-01)

Expression of the Long Noncoding RNA GAS5 Correlates with Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
by: Man-Hoon Han, et al.
Published: (2020-05-01)

Neurologic Safety of Etomidate-Based Sedation during Upper Endoscopy in Patients with Liver Cirrhosis Compared with Propofol: A Double-Blind, Randomized Controlled Trial
by: Jang Han Jung, et al.
Published: (2020-07-01)

Management of Patients with Chronic Liver Disease: The Era of the COVID-19 Pandemic
by: Yu Rim Lee
Published: (2021-04-01)

Role of Microbiota-Derived Metabolites in Alcoholic and Non-Alcoholic Fatty Liver Diseases
by: Ji-Won Park, et al.
Published: (2021-12-01)

Correspondence on Letter regarding “Evidence-based hyponatremia management in liver disease”
by: Ji Young Ryu, et al.
Published: (2023-10-01)

Association Between Low Muscle Mass and Non-alcoholic Fatty Liver Disease Diagnosed Using Ultrasonography, Magnetic Resonance Imaging Derived Proton Density Fat Fraction, and Comprehensive NAFLD Score in Korea
by: Hun Ju Lee, et al.
Published: (2021-11-01)

Tumor Recurrence in Hepatocellular Carcinoma Patients after Radiofrequency Ablation: Portal Hypertension as an Indicator of Recurrence of Hepatocellular Carcinoma
by: Seong Won Jang, et al.
Published: (2018-11-01)

A Case of Hepatic Immunoglobulin G4-Related Disease Presenting as an Inflammatory Pseudotumor and Sclerosing Cholangitis
by: Se Young Jang, et al.
Published: (2022-06-01)

Usefulness of Psoas Muscle Cross-Sectional Area in Evaluating Physical Performance in Patients with Liver Cirrhosis
by: Bo Seong Jang, et al.
Published: (2020-12-01)

Association between new-onset liver cirrhosis and suicide risk in South Korea: A nationwide cohort study
by: Suk-Yong Jang, et al.
Published: (2021-04-01)

Environmental risk factors and comorbidities of primary biliary cholangitis in Korea: a case-control study
by: Kyung-Ah Kim, et al.
Published: (2021-03-01)

Postoperative alterations in ventriculoarterial coupling are an indicator of cardiovascular outcomes in liver transplant recipients
by: Ji Yeon Kim, et al.
Published: (2024-04-01)

Reappraisal of sepsis-3 and CLIF-SOFA as predictors of mortality in patients with cirrhosis and infection presenting to the emergency department: A multicenter study
by: Ji Hyun Kim, et al.
Published: (2022-07-01)

Hyponatremia in Liver Cirrhosis
by: Cheolmin Jang, et al.
Published: (2018-08-01)

Management of liver diseases during the pandemic of coronavirus disease-19
by: Ju-Yeon Cho, et al.
Published: (2020-07-01)

The Role of the Gut Microbiome in Liver Cirrhosis Treatment
by: Na Young Lee, et al.
Published: (2020-12-01)

Clinical application of ultrasonography-guided percutaneous liver biopsy and its safety over 18 years
by: Young Chang, et al.
Published: (2020-07-01)

Update on liver disease management during the pandemic of coronavirus disease 2019 (COVID-19): 2021 KASL guideline
by: Ju-Yeon Cho, et al.
Published: (2021-10-01)

Risk of Liver Cirrhosis and Hepatocellular Carcinoma after Fontan Operation: A Need for Surveillance
by: Jun Sik Yoon, et al.
Published: (2020-07-01)

Intravenous albumin for the prevention of contrast-induced nephropathy in patients with liver cirrhosis and chronic kidney disease undergoing contrast-enhanced CT
by: Heejung Choi, et al.
Published: (2012-06-01)

Formyl Peptide Receptor 2 Alleviates Hepatic Fibrosis in Liver Cirrhosis by Vascular Remodeling
by: Ji Hye Jun, et al.
Published: (2021-02-01)

Platelet-to-White Blood Cell Ratio Is Associated with Adverse Outcomes in Cirrhotic Patients with Acute Deterioration
by: Jung Hee Kim, et al.
Published: (2022-04-01)